Effects of decylubiquinone (coenzyme Q10 analog) supplementation on SHRSP

BioFactors

Volumn 30, Issue 1, 2007, Pages 13-18

  Murad, Leonardo Borges ^a   Guimarães, Marcela Rodrigues Moreira ^a   Vianna, Lucia Marques ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

Author keywords

Blood glucose levels; Decylubiquinone; HDL cholesterol; LDL cholesterol; Malondialdehyde; Oxidative stress; SHRSP; Systolic blood pressure; Total cholesterol; Triglycerides

Indexed keywords

2 DECYL 5,6 DIMETHOXY 3 METHYL 1,4 BENZOQUINONE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; COCONUT OIL; DECYLUBIQUINONE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL; UBIDECARENONE; UBIQUINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIURESIS; DRUG POTENCY; ENZYME ANALYSIS; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPECIES IDENTIFICATION; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; ANTIOXIDANTS; BLOOD GLUCOSE; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; LIPIDS; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; UBIQUINONE;

RATTUS;

EID: 38049161857     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520300102     Document Type: Article

References (20)

1. H.S. Al-Thakafy, S.M. Khoja and K.M. Al-marzouki, Alterations of erythrocyte free radical defense system, heart tissue lipid peroxidation, and lipid concentration in streptozotocin-induced diabetic rats under coenzyme Q10 supplementation, Saudi Med J 12(25) (2004), 1824-1830.
2. J.S. Armstrong, M. Whiteman, P. Rose and D.P. Jones, The Coenzyme Q10 analog decylubiquinone inhibits the redox-activated mitochondrial permeability transition: role of mitcohondrial correction mitochondrial Complex III, J Biol Chem 278 (2003), 49079-49084.
3. J.J. Briere, D. Schlemmer, D. Chretien and P. Rustin, Quinone analogues regulate mitochondrial substrate competitive oxidation, Biochem Biophys Res Commun 316 (2004), 1138-1142.
4. C.M. Cao, J.Z. Chen, Q. Xia, S.Z. Zhang, G.H. Lin and T.M. Wong, Interleukin-2 confers cardioprotection by inhibiting mitochondrial permeability transition pore, Conf Proc IEEE Eng Med Biol Soc 5 (2004), 3618-3621.
5. A. Danysz, K. Oledzka and K. Bukowska-Kiliszek, Influence of coenzyme Q-10 on the hypotensive effects of enalapril and nitrendipine in spontaneously hypertensive rats, Pol J Pharamacol 46 (1994), 457-461.
6. D.K. Das and N. Maulik, Mitochondrial function in cardiomyocytes: target for cardioprotection, Curr Opin Anaesthesiol 18 (2005), 77-82.
7. F.I. Fontaine and P. Bernardi, Ubiquinone-binding site regulates the mitochondrial permeability transition pore, J Biol Chem 273 (1998), 25734-25740.
8. V. Geromel, N. Darin, D. Chretien, P. Benit, P. DeLonlay, A. Rotig, A. Munnich and P. Rustin, Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits, Mol Genet Metab 77 (2002), 21-30.
9. S. Martinucci, I. Szabo, F. Tombola and M. Zoratti, Ca2.-reversible inhibition of the mitochondrial megachannel by ubiquinone analogues, FEBS Letters 480 (2000), 89-94.
10. M.W. McBride, M.J. Brosnan and J. Mathers, Reduction of Gstm1 Expression in the Stroke-Prone Spontaneously Hypertension Rat Contributes to Increased Oxidative Stress, Hypertension 45 (2005), 786-792.
11. M.R. McCall, J.Y. Tang, J.K. Bielicki and T.M. Forte, Inhibition of lecithin-cholesterol acyltransferase and modification of HDL apolipoproteins by aldehydes, Arterioscler Thromb Vasc Biol 15 (1995), 1599-1606.
12. M. McIntre, C. Hamilton, D. Rees, J. Reid and A. Dominiczak, Sex difference in the abundance of endothelial nitric oxide in a model of genetic hypertension, Hypertension 30 (1997), 1517-1524.
13. A. Michihara, M. Sawamura, Y. Yamori, K. Akasaki and H. Tsuji, Comparison of subcellular distribution of mevalonate pyrophosphate decarboxylase between stroke-prone spontaneously hypertensive rat and wistar kyoto rat, Biol Pharm Bull 25 (2002), 734-737.
14. K. Modi, D.D Santani and R.K. Goyal, Effect of coenzyme Q10 on catalase activity and other antioxidant parameters in streptozotocin-induced diabetic rats, Biol Trace Elem Res 109 (2006), 25-34.
15. H. Okamoto and H. Kawaguchi, Togashi, Effect of coenzyme Q10 on structural alterations in the renal membrane of stroke-prone spontaneously hypertensive rats, Biochem Med Metab Biol 45 (1991), 216-226.
16. M. Ott, V. Gogvadze, S. Orrenius and B. Zhivotovsky, Mitochondria, oxidative stress and cell death, Apoptosis 12 (2007), 913-922.
17. Praticò, Antioxidants and endothelium protection: Review, Atherosclerosis 181 (2005), 215-224.
18. R. Rodrigo, J.P. Bachler, J. Araya, H. Prat and W. Passalacqua, Relationship between (Na + K)-ATPase activity, lipid peroxidation and fatty acid profile in erythrocytes of hypertensive and normotensive subjects, Mol Cell Biochem (2007), Epub ahead of print.
19. L.Walter, V. Nogueira, X. Leverve, M.P. Heitz, P. Bernardi and E. Fontaine, Three classes of ubiquinone analogs regulate the mitochondrial permeability transition pore through a common site, J Biol Chem 275 (2000), 29521-29529.
20. L.M. Yung, F.P. Leung, X. Yao, Z.Y. Chen and Y. Huang, Reactive oxygen species in vascular wall, Cardiovasc Hematol Disord Drug Targets 6 (2006), 1-19.